Keyphrases
People with Schizophrenia
100%
Antipsychotics
100%
Health-related Quality of Life
100%
Schizophrenia Spectrum Disorders
100%
Cardiometabolic Health
100%
Relative Risk
66%
Obesity
50%
Cardiovascular Disease
50%
Cardiovascular Risk
50%
Defined Daily Dose
50%
Cardiometabolic Risk
50%
High Dose
33%
Body Mass Index
33%
Clozapine
33%
Antipsychotic Polypharmacy
33%
Hong Kong
16%
Chinese People
16%
Regression Model
16%
Weight Gain
16%
Young Age
16%
Chinese Patients
16%
Community-based
16%
Young Males
16%
Patients with Schizophrenia
16%
Baseline Measurements
16%
Hong Kong Population
16%
Poor Health
16%
Male Gender
16%
Trial Registration
16%
Mental Quality of Life
16%
Potential Relationships
16%
Metabolic Syndrome
16%
Physical Health-related Quality of Life
16%
Metabolic Syndrome Prevalence
16%
Waist Circumference
16%
Medication Regimen
16%
Cardiovascular Disease Risk Score
16%
Obesity Risk
16%
Dose Equivalent
16%
Young Male Patients
16%
QRISK2
16%
Disease Risk Screening
16%
10-year Cardiovascular Disease Risk
16%
People with Severe Mental Illness
16%
High Body Mass Index
16%
Physical Health Intervention
16%
Medicine and Dentistry
Cardiovascular Disease
100%
Schizophrenia Spectrum Disorder
100%
Quality of Life
100%
Cross Sectional Study
100%
Body Mass Index
42%
Antipsychotic
42%
Metabolic Syndrome
28%
Drug Megadose
28%
Clozapine
28%
Polypharmacy
28%
Mental Health
14%
Prevalence
14%
Severe Mental Illness
14%
Equivalent Dose
14%
Clinician
14%
Cardiometabolic Risk
14%
Nursing and Health Professions
Quality of Life
100%
Cross-Sectional Study
100%
Schizophrenia Spectrum Disorder
100%
Cardiovascular Disease
100%
Body Mass
42%
Metabolic Syndrome X
28%
Drug Megadose
28%
Clozapine
28%
Polypharmacy
28%
Mental Health
14%
Prevalence
14%
Equivalent Dose
14%
Waist Circumference
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cross-Sectional Study
100%
Schizophrenia Spectrum Disorder
100%
Cardiovascular Disease
100%
Defined Daily Dose
42%
Antipsychotic
42%
Metabolic Syndrome X
28%
Clozapine
28%
Polypharmacy
28%
Prevalence
14%
Psychology
Quality of Life
100%
Schizophrenia
100%
Body Mass Index
42%
Metabolic Syndrome
28%
Mental Illness
14%
Baseline Measurement
14%
Regression Model
14%
Mental Health
14%
Weight Gain
14%
Neuroscience
Schizophrenia Spectrum Disorder
100%
Body Mass Index
50%
Antipsychotic
50%
Clozapine
33%
Severe Mental Illness
16%